These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8998585)

  • 1. [Results of IVF and ET 1992-95 at the Gynecological-Obstetrical Clinic in Olomouc--comparison of stimulation protocols].
    Oborná I; Talas M; Dostál J; Chrastinová L; Kudela M
    Ceska Gynekol; 1996 Dec; 61(6):349-51. PubMed ID: 8998585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of short and long ovulation induction protocols used in ART applications according to the ovarian response and outcome of pregnancy.
    Tavmergen E; Göker EN; Sendag F; Sendag H; Levi R
    Arch Gynecol Obstet; 2002 Jan; 266(1):5-11. PubMed ID: 11998967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Highly purified FSH for stimulation of down regulated cycles in the in vitro fertilization program].
    Sydow P; Lisse K; Schürenkämper P; Scheiber I; Bloechle M
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):146-50. PubMed ID: 8674961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
    Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
    Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between IVF and GIFT using the GnRH agonist protocol.
    Cittadini E; Palermo R; Agrifoglio V
    Acta Eur Fertil; 1988; 19(1):41-4. PubMed ID: 3137763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age.
    Weghofer A; Margreiter M; Bassim S; Sevelda U; Beilhack E; Feichtinger W
    Fertil Steril; 2004 Apr; 81(4):1002-6. PubMed ID: 15066455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a.
    Karacan M; Erkan H; Karabulut O; Sarikamiş B; Camlibel T; Benhabib M
    J Reprod Med; 2001 May; 46(5):485-9. PubMed ID: 11396377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis.
    Agrawal R; Holmes J; Jacobs HS
    Fertil Steril; 2000 Feb; 73(2):338-43. PubMed ID: 10685540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of the use of low dose human menopausal gonadotropin in ovulation induction.
    Ku SY; Suh CS; Kim SH; Choi YM; Kim JG; Moon SY
    Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):55-9. PubMed ID: 12818444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
    Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
    Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation induction for in-vitro-fertilization and embryo transfer applying decapeptyl (DTRP-6 LH/RH) in combination with HMG or FSH.
    Mettler L; Argiriou C; Abd-el Maeboud K; Steinmüller H; Semm K
    Exp Clin Endocrinol; 1988 Mar; 92(3):245-51. PubMed ID: 2978123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of the ratio in FSH/LH of human menopausal gonadotropins in a programmed stimulation regimen for IVF-ET].
    Ikenaga H
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1223-9. PubMed ID: 8543846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin stimulation after pituitary desensitization with leuprolide acetate, comparison of FSH/hMG and hMG alone cycles--a study of 166 cases.
    Hwang FR; Chang MY; Soong YK
    Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):223-30. PubMed ID: 8313205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.